medical provider before receiving treatment
Pace & Goals Set a goal weight and a weekly pace, then track actual against target
These symptoms reflect both the medication's action and the body's adjustment to a sudden deficit in energy intake
Based on the review, the researchers reported the following findings: Patients who received weekly 50 mg oral semaglutide reported a higher incidence of altered skin sensations, such as dysesthesia (1.8% versus 0%), hyperesthesia (1.2% versus 0%), skin pain (2.4% versus 0%), paresthesia (2.7% versus 0%), and sensitive skin (2.7% versus 0%), than those receiving placebo or comparator
Patients should feel empowered to ask questions, express concerns, and participate actively in shared decision-making regarding their weight management treatment plan